Cao Ma
Research Subjects
Cao Ma has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Zhiwen Zhang
Fuwai Central China Cardiovascular Hospital, Zhengzhou, China
2 shared publicationsDonghui Chen
Zhengzhou University People's Hospital, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital Zhengzhou China
1 shared publicationHaosen Yu
Zhengzhou University People's Hospital, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital Zhengzhou China
1 shared publicationMingxing Lv
Zhengzhou University People's Hospital, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital Zhengzhou China
1 shared publicationMuwei Li
Fuwai Central China Cardiovascular Hospital, Zhengzhou, China
1 shared publication- Muwei Li
Department of Cardiology, Fuwai Central China Cardiovascular Hospital, Central China Fuwai Hospital of Zhengzhou University
1 shared publication
Latest Publications
- Open Access
- 17 February 2026
- Published by Elsevier in JACC: Cardiooncology
- Vol. 8 (1) , 98
Refining Free Light Chain Ratio in Systemic Amyloidosis
- 17 February 2026
- Published by Elsevier in JACC: Cardiooncology
- Vol. 8 (1) , 98
Open AccessRefining Free Light Chain Ratio in Systemic Amyloidosis
- Open Access
- 2 December 2025
- Published by Wiley in Clinical Cardiology
- Vol. 48 (12) , e70226
Impact of Insomnia on Myocardial Infarction Risk and Coronary Plaque Vulnerability: Insights From Mendelian Randomization and OCT Imaging
Background: Insomnia is a prevalent sleep disorder increasingly recognized as a risk factor for cardiovascular diseases (CVDs). However, its causal relationship with myocardial infarction (MI) and its impact on coronary plaque vulnerability remain poorly understood. Methods: We performed Mendelian randomization (MR) analysis using genome‐wide association study (GWAS) summary data for insomnia ( n = 462,341) and MI ( n = 484,598) in populations of European descent. Additionally, 340 patients with coronary artery disease (CAD) underwent coronary angiography and optical coherence tomography (OCT) imaging. Insomnia was assessed by the Insomnia Severity Index (ISI), and OCT was used to evaluate plaque features including thin‐cap fibroatheroma (TCFA), fibrous cap thickness, lipid arc, macrophage infiltration, and plaque rupture. Results: MR analysis showed a potential causal effect of genetically predicted insomnia on MI risk (OR = 1.015; 95% CI: 1.004–1.027; p = 0.007), with no evidence of pleiotropy or heterogeneity. Clinically patients with insomnia (ISI ≥ 8) had higher rates of hypertension (54.3% vs. 39.6%) and MI (32.4% vs. 21.7%), elevated CRP levels, and exhibited greater plaque vulnerability on OCT, including increased incidence of TCFA (29.5% vs. 17.0%), thinner fibrous caps, larger lipid arcs, and more frequent macrophage infiltration and plaque rupture. Logistic regression identified both insomnia (OR = 1.806; p = 0.037) and CRP (OR = 1.384; p = 0.034) as independent predictors of TCFA. Conclusions: This study provides genetic and clinical evidence that insomnia contributes to MI risk and coronary plaque vulnerability, underscoring the importance of addressing sleep disturbances in CAD management.
- 2 December 2025
- Published by Wiley in Clinical Cardiology
- Vol. 48 (12) , e70226
Open AccessImpact of Insomnia on Myocardial Infarction Risk and Coronary Plaque Vulnerability: Insights From Mendelian Randomization and OCT Imaging
Background: Insomnia is a prevalent sleep disorder increasingly recognized as a risk factor for cardiovascular diseases (CVDs). However, its causal relationship with myocardial infarction (MI) and its impact on coronary plaque vulnerability remain poorly understood. Methods: We performed Mendelian randomization (MR) analysis using genome‐wide association study (GWAS) summary data for insomnia ( n = 462,341) and MI ( n = 484,598) in populations of European descent. Additionally, 340 patients with coronary artery disease (CAD) underwent coronary angiography and optical coherence tomography (OCT) imaging. Insomnia was assessed by the Insomnia Severity Index (ISI), and OCT was used to evaluate plaque features including thin‐cap fibroatheroma (TCFA), fibrous cap thickness, lipid arc, macrophage infiltration, and plaque rupture. Results: MR analysis showed a potential causal effect of genetically predicted insomnia on MI risk (OR = 1.015; 95% CI: 1.004–1.027; p = 0.007), with no evidence of pleiotropy or heterogeneity. Clinically patients with insomnia (ISI ≥ 8) had higher rates of hypertension (54.3% vs. 39.6%) and MI (32.4% vs. 21.7%), elevated CRP levels, and exhibited greater plaque vulnerability on OCT, including increased incidence of TCFA (29.5% vs. 17.0%), thinner fibrous caps, larger lipid arcs, and more frequent macrophage infiltration and plaque rupture. Logistic regression identified both insomnia (OR = 1.806; p = 0.037) and CRP (OR = 1.384; p = 0.034) as independent predictors of TCFA. Conclusions: This study provides genetic and clinical evidence that insomnia contributes to MI risk and coronary plaque vulnerability, underscoring the importance of addressing sleep disturbances in CAD management.